TABLE OF CONTENT: 1. Introduction 1.1. Research Scope 1.2. Market Segmentation 1.3. Research Methodology 1.4. Definitions and Assumptions 2. Executive Summary 3. Market Dynamics 3.1. Market Drivers 3.2. Market Restraints 3.3. Market Opportunities 4. Key Insights 4.1 Prevalence Of Diabetes By Key Countries 4.2 Pricing Analysis, By Key Regions 4.3 Technological Advancements 4.4 Recent Industry Developments,Mergers & Acquisitions 5. Global Diabetes Monitoring Devices Market Analysis, Insights and Forecast, 2015-2026 5.1. Key Findings / Summary 5.2. Market Analysis, Insights and Forecast – By Product 5.2.1 Blood Glucose Meters 5.2.2 Test Strips 5.2.3 Lancets 5.2.4 Others 5.3. Market Analysis, Insights and Forecast – By End User 5.3.1 Institutional Sales 5.3.1.1 Hospitals 5.3.1.2 Clinics 5.3.1.3 Others 5.3.2 Retail Sales 5.3.2.1 Hospital Pharmacies 5.3.2.2 Retail Pharmacies 5.3.2.3 Online Pharmacies 5.4. Market Analysis, Insights and Forecast – By Region 5.4.1 North America 5.4.2 Europe 5.4.3 Asia Pacific 5.4.4 Latin America 5.4.5 Middle East & Africa 6. North America Diabetes Monitoring Devices Market Analysis, Insights and Forecast, 2015-2026 6.1. Key Findings / Summary 6.2. Market Analysis – By Product 6.2.1 Blood Glucose Meters 6.2.2 Test Strips 6.2.3 Lancets 6.2.4 Others 6.3. Market Analysis, Insights and Forecast – By End User 6.3.1 Institutional Sales 6.3.1.1 Hospitals 6.3.1.2 Clinics 6.3.1.3 Others 6.3.2 Retail Sales 6.3.2.1 Hospital Pharmacies 6.3.2.2 Retail Pharmacies 6.3.2.3 Online Pharmacies 6.4. Market Analysis, Insights and Forecast – By Country 6.4.1 U.S. 6.4.2 Canada 7. Europe Diabetes Monitoring Devices Market Analysis, Insights and Forecast, 2015-2026 7.1. Key Findings / Summary 7.2. Market Analysis, Insights and Forecast – By Product 7.2.1 Blood Glucose Meters 7.2.2 Test Strips 7.2.3 Lancets 7.2.4 Others 7.3. Market Analysis, Insights and Forecast – By End User 7.3.1 Institutional Sales 7.3.1.1 Hospitals 7.3.1.2 Clinics 7.3.1.3 Others 7.3.2 Retail Sales 7.3.2.1 Hospital Pharmacies 7.3.2.2 Retail Pharmacies 7.3.2.3 Online Pharmacies 7.4. Market Analysis, Insights and Forecast – By Country/ Sub-region 7.4.1 U.K. 7.4.2 Germany 7.4.3 Italy 7.4.4 Spain 7.4.5 France 7.4.6 Scandinavia 7.4.7 Rest of Europe 8. Asia Pacific Diabetes Monitoring Devices Market Analysis, Insights and Forecast, 2015-2026 8.1. Key Findings / Summary 8.2. Market Analysis, Insights and Forecast – By Product 8.2.1 Blood Glucose Meters 8.2.2 Test Strips 8.2.3 Lancets 8.2.4 Others 8.3. Market Analysis, Insights and Forecast – By End User 8.3.1 Institutional Sales 8.3.1.1 Hospitals 8.3.1.2 Clinics 8.3.1.3 Others 8.3.2 Retail Sales 8.3.2.1 Hospital Pharmacies 8.3.2.2 Retail Pharmacies 8.3.2.3 Online Pharmacies 8.4. Market Analysis, Insights and Forecast – By Country/ Sub-region 8.4.1 China 8.4.2 Australia 8.4.3 India 8.4.4 Japan 8.4.5 Southeast Asia 8.4.6 Rest of Asia Pacific 9. Latin America Diabetes Monitoring Devices Market Analysis, Insights and Forecast, 2015-2026 9.1. Key Findings / Summary 9.2. Market Analysis, Insights and Forecast – By Product 9.2.1 Blood Glucose Meters 9.2.2 Test Strips 9.2.3 Lancets 9.2.4 Others 9.3. Market Analysis, Insights and Forecast – By End User 9.3.1 Institutional Sales 9.3.1.1 Hospitals 9.3.1.2 Clinics 9.3.1.3 Others 9.3.2 Retail Sales 9.3.2.1 Hospital Pharmacies 9.3.2.2 Retail Pharmacies 9.3.2.3 Online Pharmacies 9.4. Market Analysis, Insights and Forecast – By Country/ Sub-region 9.4.1 Brazil 9.4.2 Mexico 9.4.3 Rest of Latin America 10. Middle East &Africa Diabetes Monitoring Devices Market Analysis, Insights and Forecast,2015-2026 10.1. Key Findings / Summary 10.2. Market Analysis, Insights and Forecast – By Product 10.2.1 Blood Glucose Meters 10.2.2 Test Strips 10.2.3 Lancets 10.2.4 Others 10.3. Market Analysis, Insights and Forecast – By End User 10.3.1 Institutional Sales 10.3.1.1 Hospitals 10.3.1.2 Clinics 10.3.1.3 Others 10.3.2 Retail Sales 10.3.2.1 Hospital Pharmacies 10.3.2.2 Retail Pharmacies 10.3.2.3 Online Pharmacies 10.4. Market Analysis, Insights and Forecast – By Country/ Sub-region 10.4.1 South Africa 10.4.2 GCC 10.4.3 Rest of Middle East &Africa 11. Competitive Analysis 11.1. Key Industry Developments 11.2. Global Market Share Analysis (2018) 11.3. Competition Dashboard 11.4. Comparative Analysis –Major Players 11.4.1 F.Hoffmann-La Roche Ltd 11.4.2 Tandem Diabetes Care, Inc. 11.4.3 B.Braun Melsungen AG 11.4.4 PHC Holdings Corporation 11.4.5 Medtronic 11.4.6 BD 11.4.7 Novo Nordisk A/S 11.4.8 Abbott 11.4.9 Other Prominent Players 12. Strategic Recommendations

Hoffmann-La Roche Ltd Dexcom, Inc. Braun Melsungen AG Medtronic Lifespan Inc. Ascensia Diabetes Care Holdings AG. Terumo Medical Corporation Abbott Sanofi DiaMonTech GmbH Other players